
Qijin (Kevin) Xu is the founder and CEO of Xcell Unity Biotech Co., focusing on cancer detection, imaging and therapy, including immunotherapy. Xu holds a B.S. in geology and chemistry from Peking University, M.S. in protein chemistry from the Chinese Academy of Sciences, and a Ph.D. in molecular, cellular and developmental biology from the University of Michigan. He is joined by partners Yingduan Cheng, Zheng (Alex) Fu, Chunying Song, and Weidong Xiong.